MABS1250 Sigma-AldrichAnti-Mineralocorticoid Receptor Antibody, clone 2D6
Detect Mineralocorticoid Receptor using this Anti-Mineralocorticoid Receptor Antibody, clone 2D6 validated for use in Western Blotting, Immunohistochemistry and Immunocytochemistry.
More>> Detect Mineralocorticoid Receptor using this Anti-Mineralocorticoid Receptor Antibody, clone 2D6 validated for use in Western Blotting, Immunohistochemistry and Immunocytochemistry. Less<<Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
Species Reactivity | Key Applications | Host | Format | Antibody Type |
---|---|---|---|---|
R | WB, IHC, ICC | M | Purified | Monoclonal Antibody |
References |
---|
Product Information | |
---|---|
Format | Purified |
Presentation | Purified mouse monoclonal IgG2aκ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide. |
Quality Level | MQ100 |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Storage and Shipping Information | |
---|---|
Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
Packaging Information | |
---|---|
Material Size | 200 μg |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
MABS1250 | 04055977173031 |
Documentation
Anti-Mineralocorticoid Receptor Antibody, clone 2D6 SDS
Title |
---|
Anti-Mineralocorticoid Receptor Antibody, clone 2D6 Certificates of Analysis
Title | Lot Number |
---|---|
Anti-Mineralocorticoid Receptor, -Q2573211 | Q2573211 |
Anti-Mineralocorticoid Receptor, clone 2D6 - 3245604 | 3245604 |
Anti-Mineralocorticoid Receptor, clone 2D6 - 3884760 | 3884760 |
Anti-Mineralocorticoid Receptor, clone 2D6 - 4209927 | 4209927 |
Technical Info
Title |
---|
Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
White Paper: Further considerations of antibody validation and usage. |